Biotest is committed to combating the coronavirus

Activities of Biotest Group against the coronavirus

TV reports, press releases and the presentation of Biotest's research activities.

CoVIg-19 PLASMA ALLIANCE

The fight against COVID-19 begins with you.

You have recovered. Then you can save others.

We are developing a potential drug. First, we need your plasma.

Be part of this historic initiative to fight the coronavirus pandemic.

Our product range

Our development pipeline

Phase 1

Phase 2

Phase 3

Approval

Launch

IgG Next Generation (BT595) - Primary Immune Deficiency (PID)
IgG Next Generation (BT595) - Idiopathic Thrombocytopenic Purpura (ITP)
Fibrinogen (BT524) - Congenital fibrinogen deficiency
Fibrinogen (BT524) - Acquired fibrinogen deficiency
Trimodulin (BT588) - Severe community acquired pneumonia
Haemophilia A Therapeutic (HAT) - Haemophilia A

Pipeline

Overview of all projects and their status from the therapy areas Haematology, Immunology and Intensive care medicine

Press releases

Biotest presented promising data on next generation rec...

21.07.2020,

21.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest Supervisory Board extends contracts with the Bo...

20.07.2020,

20.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest submits phase II study with trimodulin for the ...

16.07.2020,

16.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Preliminary announcement of the publication of financia...

09.07.2020,

09.07.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of financia...

09.07.2020,

09.07.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Biotest successfully enters China, the world's biggest ...

10.06.2020,

10.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest's Zutectra(R) demonstrates improved quality of ...

08.06.2020,

08.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest achieves significant milestone by completing ph...

26.05.2020,

26.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest increases sales by 26%

08.05.2020,

08.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Annual General Meeting approves dividend distribution

08.05.2020,

08.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest produces life-saving medicine derived from plas...

06.04.2020,

06.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest is developing with Trimodulin a COVID-19 therap...

03.04.2020,

03.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest exceeds EBIT forecast in the 2019 financial yea...

30.03.2020,

30.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Release according to Article 40, Section 1 of the WpHG ...

02.03.2020,

02.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Biotest exceeds already raised EBIT guidance

26.02.2020,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Biotest exceeds already raised EBIT guidanceDreieich, 26 February 2020. According to preliminary and unaudited figures, the B ... [More]

Release according to Article 40, Section 1 of the WpHG ...

25.02.2020,

25.02.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Biotest's CMV-specific hyperimmunoglobulin Cytotect CP ...

15.01.2020,

15.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest hosts first international symposium to increase...

17.12.2019,

17.12.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG opens fourth plasma collection centre in Cze...

11.12.2019,

11.12.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG increases Guidance

04.12.2019,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Biotest AG increases GuidanceDreieich, 4 December 2019. Following the evaluation of the current business situation, the Manag ... [More]

Careers

Careers

Passionate to help us save lives?

Investor Relations

Investor Relations

The primary objective of our Investor Relations activities is an open and up-to-date dialogue with the financial community.